Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cube Biotech logo — The native drug discovery enablers for complex targets. Let'...

Cube Biotech

The native drug discovery enablers for complex targets. Let's pioneer together!

Founded 2012 Germany Monheim, Germany 54 employees Unknown Biotechnology, Health Care +1

General Information

Company Name Cube Biotech
Founded Year 2012
Location Germany Monheim, Germany +3
Employees 54
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Unknown
Social

Get notified when Cube Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cube Biotech

Cube Biotech, founded in 2012, is a Germany-based contract research organization specializing in advancing drug discovery for complex targets, particularly membrane proteins. With a unique synthetic copolymer portfolio, Cube Biotech enables more reliable and native membrane protein research compared to traditional detergents.

Offering tailored non-GMP services, the company assists clients in protein preparation, biophysical target characterization, and structure determination via cryo-EM and assay development. Their service models, ranging from FTE-based to milestone-based, provide flexibility and customization akin to building with Lego bricks.

Positioned within the Biotechnology, Health Care, and Pharmaceutical sectors, Cube Biotech seeks enduring collaborations with industrial and academic partners. The company received its last investment through a buyout on 01 November 2021, backed by ArchiMed. A potential investment in Cube Biotech offers exposure to innovative biotech solutions and a partnership-driven approach to drug discovery.

Taxonomy: Membrane Protein Research, Contract Research Organization, Protein Preparation, Biophysical Target Characterization, Cryo-EM Structure Determination, Synthetic Copolymers, Drug Discovery Enablers, Protein Services Customization, FTE-Based Models, Milestone-Based Models, Structure Analysis of Membrane Proteins, GPCRs Research, Affinity Chromatography, Nanodiscs for Protein Stabilization, Pharmaceutical Research Collaboration

Services & Products

Protein Purification Products
Customized Protein Services
Bead Functionalization
Drug Target Pipeline
Educational Webinars and Publications

Target Customers

Pharmaceutical Companies Biotechnology Researchers Academic Research Institutions Drug Discovery Professionals Membrane Protein Scientists

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Buyout •••••• 1
Investor
01 Nov 2021
Series A •••••• 1
Investor
01 Dec 2012

Cube Biotech Alternatives & Competitors

Cube Biotech vs
Creative Biostructure
Creative Biostructure United States

Our Mission is to Develop Creative Structure-based Therapies

201-500 employees
Biopharma, Biotechnology
Cube Biotech vs
Nuclera
Nuclera United Kingdom

Bring rapid protein access to your benchtop with eProtein Discovery

Series C
116 employees
Biotechnology, Life Sciences
Compare Cube Biotech vs Nuclera
Cube Biotech vs
Nexomics Biosciences
Nexomics Biosciences United States

Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical communit...

10 employees
Biopharma, Biotechnology
Compare Cube Biotech vs Nexomics Biosciences
Also compare with: Cube Biotech vs Ciloa SAS Ciloa SAS

FAQ About Cube Biotech

The native drug discovery enablers for complex targets. Let's pioneer together!
Cube Biotech was founded in 2012.
Cube Biotech is headquartered in Monheim, Germany.
Cube Biotech operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Cube Biotech has approximately 54 employees.
Cube Biotech has completed 2 funding rounds. The latest funding stage is Unknown.
Cube Biotech offers: Protein Purification Products, Customized Protein Services, Bead Functionalization, Drug Target Pipeline, Educational Webinars and Publications.
Top alternatives and competitors to Cube Biotech include Creative Biostructure, Nuclera, Nexomics Biosciences, Ciloa SAS, Integral Molecular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cube Biotech and Creative Biostructure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cube Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy